Results 61 to 70 of about 11,061 (219)
Revisiting beta‐2 microglobulin as a prognostic marker in diffuse large B‐cell lymphoma
Cancer Medicine, Volume 13, Issue 12, June 2024.Beta‐2 microglobulin (β2M) has been sporadically incorporated in prognostic models for diffuse large B‐cell lymphoma (DLBCL). We compared the prognostic discriminative ability of four existing DLBCL models with International Prognostic Indices. Moreover, we developed and validated a new model from the largest population investigating this marker so far,
Jelena Jelicic +11 more
wiley +1 more source
Revista Universitas Medica, 2010 El linfoma primario de recto es un tumor intestinal, poco frecuente, que está constituido, principalmente, por el tipo no Hodgkin extraganglionar y corresponde de 0,2% a 0,6% de todos los tumores de colon y recto.
LIDA MILENA APONTE
doaj
Hematological Oncology, Volume 42, Issue 2, March 2024.Abstract Chronic lymphocytic leukemia (CLL) is the most common leukemia in western societies, recognized by clinical and molecular heterogeneity. Despite the success of targeted therapies, acquired resistance remains a challenge for relapsed and refractory CLL, as a consequence of mutations in the target or the upregulation of other survival pathways ...
Nayla Mouawad +6 more
wiley +1 more source
Antibody targeting of mutant calreticulin in myeloproliferative neoplasms
Journal of Cellular and Molecular Medicine, Volume 28, Issue 5, March 2024.Overview of pathogenic mechanisms of mutant calreticulin (CALR) in myeloproliferative neoplasms (MPN) and potential ways to target the mutant calreticulin neoantigen by therapeutic monoclonal antibodies (mAb). 1: Mutant calreticulin is secreted and functions as an immunosuppressor. The mutant calreticulin novel C‐terminus is shown in red.
Frederike Kramer, Ann Mullally
wiley +1 more source
Linfoma gástrico no Hodgkin perforado
, 2017 Los linfomas son tumores sólidos del sistema linfático y se subdividen en linfomas de Hodgkin y no-Hodgkin. Los tumores no Hodgkin pueden originarse en tejidos no ganglionares como el tubo digestivo y son considerados primarios cuando el compromiso extranodal es igual o superior al 75% con relación al compromiso nodal.
Lizarzaburu Rodríguez, Víctor M. +4 more
openaire +3 more sources
Revista de Osteoporosis y Metabolismo Mineral, 2017 La afectación esquelética en los pacientes con linfoma no hodgkiniano (LNH) no es infrecuente. Suele ser una manifestación tardía, y cuando aparece lo hace generalmente de forma secundaria por linfomas en estadio avanzado y con alta carga tumoral.
Rodríguez Duque JC +5 more
doaj +1 more source
Factores pronósticos en el linfoma de Hodgkin. Revisión de una serie clínica [PDF]
, 2019 El linfoma de Hodgkin (LH) es un tipo de neoplasia maligna de origen clonal, que deriva de los linfocitos B del centro germinal de los ganglios linfáticos y constituye el 10% de todos los linfomas.
Antón Rodríguez, Ángela +1 more
core
Classification of haematopoietic and lymphoid tumors: WHO, standardization of nomenclature in Portuguese, 4th edition [PDF]
, 2011 INTRODUCTION: The World Health Organization (WHO) classification of hematopoietic and lymphoid tissue (4th edition, 2008) tumors constitutes an updated review of the 3rd edition published in 2001.
Aldred, Vera Lucia +13 more
core +2 more sources
Leucemia Linfoblástica aguda recidivada tratada com rituximab: relato de caso e revisão de literatura. [PDF]
, 2007 Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina. Curso de Medicina.
Borbinhão, Rodrigo Widholzer
core
Primary Effusion Lymphoma in a HIV Infected Patient [PDF]
, 2012 O linfoma primário das cavidades é um subtipo de linfoma não-Hodgkin (LNH), de ocorrência rara, prognóstico muito reservado, mais frequentemente descrito em indivíduos imunodeprimidos, em particular no contexto de infecção pelo vírus da imunodeficiência
Castro, M +4 more
core